中国组织工程研究与临床康复
中國組織工程研究與臨床康複
중국조직공정연구여림상강복
JOURNAL OF CLINICAL REHABILITATIVE TISSUE ENGINEERING RESEARCH
2011年
31期
5888-5890
,共3页
黄建钊%范伟%石承先%苟欣%汤可立%张莹%刘隽%余鹏%柳严
黃建釗%範偉%石承先%茍訢%湯可立%張瑩%劉雋%餘鵬%柳嚴
황건쇠%범위%석승선%구흔%탕가립%장형%류준%여붕%류엄
肝、胰头十二指肠联合切除%肝门部胆管癌%病例报告%肝移植
肝、胰頭十二指腸聯閤切除%肝門部膽管癌%病例報告%肝移植
간、이두십이지장연합절제%간문부담관암%병례보고%간이식
背景:由于肝门部解剖学的特殊性和复杂性,肝门部胆管癌长期以来都是外科治疗中的难点.目的:评价肝、胰头、十二指肠联合切除并肝移植治疗晚期肝门部胆管癌的安全性和可行性.方法:对1例Bismuth分型为Ⅳ型且合并肝门部及胰头后淋巴结转移的肝门部胆管癌患者实施肝、胰头、十二指肠联合切除并原位肝移植.肝移植后初期采用激素、他克莫司及吗替麦考酚酯三联免疫抑制治疗,激素用量较常规小并迅速撤除.对早期肝功能及胰腺功能进行连续观察,并对肿瘤标志物CA19-9进行监测.结果与结论:病理报告为中、低分化性肝门部胆管癌侵犯左、右肝管并肝方叶、肝门部及胰头后淋巴结有转移,胰头、十二指肠及切除部分胃未见癌侵犯.肝移植后患者肝功能恢复顺利,胰腺内、外分泌功能保持良好,CA19-9降至正常.术后1个月患者痊愈出院,随访1年,患者仍生存.说明肝、胰头、十二指肠联合切除并肝移植治疗肝门部胆管癌是安全可行的.
揹景:由于肝門部解剖學的特殊性和複雜性,肝門部膽管癌長期以來都是外科治療中的難點.目的:評價肝、胰頭、十二指腸聯閤切除併肝移植治療晚期肝門部膽管癌的安全性和可行性.方法:對1例Bismuth分型為Ⅳ型且閤併肝門部及胰頭後淋巴結轉移的肝門部膽管癌患者實施肝、胰頭、十二指腸聯閤切除併原位肝移植.肝移植後初期採用激素、他剋莫司及嗎替麥攷酚酯三聯免疫抑製治療,激素用量較常規小併迅速撤除.對早期肝功能及胰腺功能進行連續觀察,併對腫瘤標誌物CA19-9進行鑑測.結果與結論:病理報告為中、低分化性肝門部膽管癌侵犯左、右肝管併肝方葉、肝門部及胰頭後淋巴結有轉移,胰頭、十二指腸及切除部分胃未見癌侵犯.肝移植後患者肝功能恢複順利,胰腺內、外分泌功能保持良好,CA19-9降至正常.術後1箇月患者痊愈齣院,隨訪1年,患者仍生存.說明肝、胰頭、十二指腸聯閤切除併肝移植治療肝門部膽管癌是安全可行的.
배경:유우간문부해부학적특수성화복잡성,간문부담관암장기이래도시외과치료중적난점.목적:평개간、이두、십이지장연합절제병간이식치료만기간문부담관암적안전성화가행성.방법:대1례Bismuth분형위Ⅳ형차합병간문부급이두후림파결전이적간문부담관암환자실시간、이두、십이지장연합절제병원위간이식.간이식후초기채용격소、타극막사급마체맥고분지삼련면역억제치료,격소용량교상규소병신속철제.대조기간공능급이선공능진행련속관찰,병대종류표지물CA19-9진행감측.결과여결론:병리보고위중、저분화성간문부담관암침범좌、우간관병간방협、간문부급이두후림파결유전이,이두、십이지장급절제부분위미견암침범.간이식후환자간공능회복순리,이선내、외분비공능보지량호,CA19-9강지정상.술후1개월환자전유출원,수방1년,환자잉생존.설명간、이두、십이지장연합절제병간이식치료간문부담관암시안전가행적.
BACKGROUND: Because of the specificity and complexity of hepatic portal, carcinoma of bile duct of the hepatic portal is a difficulty in the surgical treatment. OBJECTIVE: To evaluate the safety and feasibility of simultaneous pancreaticoduodenectomy and liver transplantation for the end-stage hilar cholangiocarcinoma. RESULTS AND CONCLUSION: Pathology demonstrated a middle or low differentiation of hilar cholangiocarcinoma, and left, right hepatic duct, together with lobus quadratus were invaded. The tumor metastasized to hilar and posterior pancreatic lymphonodes, without involving the head of pancreas, duodenum and stomach. The function of transplanted liver recovered smoothly, and the endocrine and exocrine functions of pancreas were kept well. CA19-9 dropped to the normal levels. The patient recovered and discharged at 1 month after surgery, and still survived after one year follow up. These suggest that simultaneous pancreaticoduodenectomy and liver transplantation as a treatment of hilar cholangiocarcinoma are safe and feasible.